Skip to content
October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk in BRCA1/2 Breast Cancer Patients landmark-cambridge-study-reveals-bilateral-salpingo-oophorectomy-significantly-reduces-early-death-risk-in-brca1-2-breast-cancer-patients
  • Medical Research and Clinical Trials

Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk in BRCA1/2 Breast Cancer Patients

Azzam Bilal Chamdy July 25, 2026
Cambridge, UK – [Insert Date] – In a groundbreaking study published in The Lancet Oncology, Cambridge researchers...
Read More Read more about Landmark Cambridge Study Reveals Bilateral Salpingo-Oophorectomy Significantly Reduces Early Death Risk in BRCA1/2 Breast Cancer Patients
The Evolving Landscape of HR-Positive Breast Cancer: Science, Treatment, and the Path to Long-Term Survivorship the-evolving-landscape-of-hr-positive-breast-cancer-science-treatment-and-the-path-to-long-term-survivorship
  • Patient Advocacy and Support

The Evolving Landscape of HR-Positive Breast Cancer: Science, Treatment, and the Path to Long-Term Survivorship

Layla Zulfa July 25, 2026
Breast cancer is not a monolithic disease; it is a complex collection of subtypes, each defined by...
Read More Read more about The Evolving Landscape of HR-Positive Breast Cancer: Science, Treatment, and the Path to Long-Term Survivorship
Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors bio-thera-solutions-initiates-phase-i-trial-for-novel-cd25-targeting-antibody-drug-conjugate-bat8013-in-advanced-solid-tumors
  • Medical Research and Clinical Trials

Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors

Asep Darmawan July 25, 2026
A pivotal Phase I clinical trial has commenced, marking a significant step forward in the development of...
Read More Read more about Bio-Thera Solutions Initiates Phase I Trial for Novel CD25-Targeting Antibody-Drug Conjugate BAT8013 in Advanced Solid Tumors
Beyond the Diagnosis: Bionews Launches “The Rare Journey” to Redefine Patient Advocacy beyond-the-diagnosis-bionews-launches-the-rare-journey-to-redefine-patient-advocacy
  • Survivorship and Post-Treatment

Beyond the Diagnosis: Bionews Launches “The Rare Journey” to Redefine Patient Advocacy

Nila Kartika Wati July 25, 2026
PENSACOLA, Florida — For the millions of individuals navigating the labyrinthine reality of a rare disease, the...
Read More Read more about Beyond the Diagnosis: Bionews Launches “The Rare Journey” to Redefine Patient Advocacy
Beyond the Rainbow: How One Journey Through Grief Redefined the Meaning of Pride beyond-the-rainbow-how-one-journey-through-grief-redefined-the-meaning-of-pride
  • Integrative Oncology and Holistic Care

Beyond the Rainbow: How One Journey Through Grief Redefined the Meaning of Pride

Asep Darmawan July 25, 2026
For decades, the concept of "Pride" has been synonymous with parades, colorful flags, and the vibrant, loud...
Read More Read more about Beyond the Rainbow: How One Journey Through Grief Redefined the Meaning of Pride
Beyond the Baseline: How Community and Early Detection Defined Tori Ashman’s Breast Cancer Journey beyond-the-baseline-how-community-and-early-detection-defined-tori-ashmans-breast-cancer-journey
  • Patient Advocacy and Support

Beyond the Baseline: How Community and Early Detection Defined Tori Ashman’s Breast Cancer Journey

Basiran July 25, 2026
In the high-stakes environment of recreational sports, the bond between teammates is often forged through sweat, competition,...
Read More Read more about Beyond the Baseline: How Community and Early Detection Defined Tori Ashman’s Breast Cancer Journey
The Battle for the Ballot: How Health Care Costs and Fraud Narratives are Defining the Midterm Landscape the-battle-for-the-ballot-how-health-care-costs-and-fraud-narratives-are-defining-the-midterm-landscape
  • Breast Cancer Legislation and Policy

The Battle for the Ballot: How Health Care Costs and Fraud Narratives are Defining the Midterm Landscape

Lina Irawan July 25, 2026
As the midterm elections approach, the American electorate is narrowing its focus on the one issue that...
Read More Read more about The Battle for the Ballot: How Health Care Costs and Fraud Narratives are Defining the Midterm Landscape
The Threshold Week: Navigating a Celestial Pivot (July 26–August 1, 2026) the-threshold-week-navigating-a-celestial-pivot-july-26-august-1-2026
  • Integrative Oncology and Holistic Care

The Threshold Week: Navigating a Celestial Pivot (July 26–August 1, 2026)

Raul Delapena Setiawan July 25, 2026
As the calendar turns to the final week of July 2026, the cosmic landscape presents a rare...
Read More Read more about The Threshold Week: Navigating a Celestial Pivot (July 26–August 1, 2026)
The Genetic Blueprint for Survival: How Tree Genomics is Rewriting the Future of Our Forests the-genetic-blueprint-for-survival-how-tree-genomics-is-rewriting-the-future-of-our-forests
  • Genomics and Precision Medicine

The Genetic Blueprint for Survival: How Tree Genomics is Rewriting the Future of Our Forests

Pevita Pearce July 25, 2026
In the quiet canopy of an Appalachian ridge or the bustling quad of a university campus, a...
Read More Read more about The Genetic Blueprint for Survival: How Tree Genomics is Rewriting the Future of Our Forests
Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue salk-institute-uncovers-estrogen-related-receptors-as-key-to-revitalizing-energy-metabolism-and-combating-muscle-fatigue
  • Medical Research and Clinical Trials

Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Pevita Pearce July 25, 2026
LA JOLLA, CA – May 12, 2025 – In a landmark study poised to redefine our understanding...
Read More Read more about Salk Institute Uncovers Estrogen-Related Receptors as Key to Revitalizing Energy Metabolism and Combating Muscle Fatigue

Posts pagination

Previous 1 … 474 475 476 477 478 479 480 … 836 Next

Recent Posts

  • A New Era in Brain Tumour Diagnosis: Nottingham Breakthrough Slashes Wait Times to Hours, Revolutionising Patient Care
  • ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide
  • Navigating Childhood Reactions: A Guide for Parents Facing Cancer
  • Beyond the Finish Line: Danielle Gabriel’s Journey from a Stage II Diagnosis to the NYC Marathon
  • The Digital Revolution in Public Health: How Mobile Payments are Empowering Africa’s Frontline Workers

Recent Comments

No comments to show.

Archives

  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-new-era-in-brain-tumour-diagnosis-nottingham-breakthrough-slashes-wait-times-to-hours-revolutionising-patient-care
  • Medical Research and Clinical Trials

A New Era in Brain Tumour Diagnosis: Nottingham Breakthrough Slashes Wait Times to Hours, Revolutionising Patient Care

Rifan Muazin October 29, 2026
esmo26-iza-bren-leads-post-tki-adcs-on-efficacy-but-toxicity-could-decide
  • Medical Research and Clinical Trials

ESMO26: Iza-bren leads post-TKI ADCs on efficacy, but toxicity could decide

Nila Kartika Wati October 29, 2026
navigating-childhood-reactions-a-guide-for-parents-facing-cancer
  • Patient Advocacy and Support

Navigating Childhood Reactions: A Guide for Parents Facing Cancer

Suro Senen October 29, 2026
beyond-the-finish-line-danielle-gabriels-journey-from-a-stage-ii-diagnosis-to-the-nyc-marathon
  • Patient Advocacy and Support

Beyond the Finish Line: Danielle Gabriel’s Journey from a Stage II Diagnosis to the NYC Marathon

Suro Senen October 29, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.